CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Private Placement, Ordinary Share Offering	Private Placement, Equity Financing Purchase Agreement	Total Pagaya Technologies Ltd. Shareholders’ Equity	Total Pagaya Technologies Ltd. Shareholders’ Equity Private Placement, Ordinary Share Offering	Total Pagaya Technologies Ltd. Shareholders’ Equity Private Placement, Equity Financing Purchase Agreement	Ordinary Shares (Class A and Class B)	Ordinary Shares (Class A and Class B) Private Placement, Ordinary Share Offering	Ordinary Shares (Class A and Class B) Private Placement, Equity Financing Purchase Agreement	Additional Paid-In Capital	Additional Paid-In Capital Private Placement, Ordinary Share Offering	Additional Paid-In Capital Private Placement, Equity Financing Purchase Agreement	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Accumulated Deficit)	Non-Controlling Interests
Beginning balance (in shares) at Dec. 31, 2023	5,000,000
Beginning balance at Dec. 31, 2023	$ 74,250
Ending balance (in shares) at Jun. 30, 2024	5,000,000
Ending balance at Jun. 30, 2024	$ 74,250
Beginning balance (in shares) at Dec. 31, 2023							62,043,246
Beginning balance at Dec. 31, 2023	665,749			$ 559,721						$ 1,101,914			$ 444	$ (542,637)	$ 106,028
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of ordinary shares upon exercise of share options (in shares)							272,918
Issuance of ordinary shares upon exercise of share options	759			759						759
Issuance of ordinary shares upon vesting of RSUs (in shares)							1,481,470
Share-based compensation	37,710			37,710						37,710
Issuance of ordinary shares, net of issuance cost and Equity Financing Purchase Agreement (in shares)								7,500,000	298,057
Issuance of ordinary shares, net of issuance cost and Equity Financing Purchase Agreement		$ 89,956	$ 5,338		$ 89,956	$ 5,338					$ 89,956	$ 5,338
Contributions of interests in consolidated VIEs	2,815														2,815
Return of capital to interests in consolidated VIEs	(5,318)														(5,318)
Other comprehensive income (loss)	(67,094)			(71,494)									(71,494)		4,400
Net income (loss)	(114,341)			(96,008)										(96,008)	(18,333)
Ending balance (in shares) at Jun. 30, 2024							71,595,691
Ending balance at Jun. 30, 2024	$ 615,574			525,982						1,235,677			(71,050)	(638,645)	89,592
Beginning balance (in shares) at Mar. 31, 2024	5,000,000
Beginning balance at Mar. 31, 2024	$ 74,250
Ending balance (in shares) at Jun. 30, 2024	5,000,000
Ending balance at Jun. 30, 2024	$ 74,250
Beginning balance (in shares) at Mar. 31, 2024							70,602,363
Beginning balance at Mar. 31, 2024	725,911			626,830						1,214,969			(24,279)	(563,860)	99,081
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of ordinary shares upon exercise of share options (in shares)							172,305
Issuance of ordinary shares upon exercise of share options	598			598						598
Issuance of ordinary shares upon vesting of RSUs (in shares)							821,023
Share-based compensation	20,093			20,093						20,093
Issuance of ordinary shares, net of issuance cost and Equity Financing Purchase Agreement	17			17						17
Return of capital to interests in consolidated VIEs	(2,803)														(2,803)
Other comprehensive income (loss)	(45,563)			(46,771)									(46,771)		1,208
Net income (loss)	(82,679)			(74,785)										(74,785)	(7,894)
Ending balance (in shares) at Jun. 30, 2024							71,595,691
Ending balance at Jun. 30, 2024	$ 615,574			525,982						1,235,677			(71,050)	(638,645)	89,592
Beginning balance (in shares) at Dec. 31, 2024	5,000,000
Beginning balance at Dec. 31, 2024	$ 74,250
Ending balance (in shares) at Jun. 30, 2025	5,000,000
Ending balance at Jun. 30, 2025	$ 74,250
Beginning balance (in shares) at Dec. 31, 2024							73,879,982
Beginning balance at Dec. 31, 2024	$ 441,546			326,491						1,282,022			(11,488)	(944,043)	115,055
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of ordinary shares upon exercise of share options (in shares)	494,281						507,909
Issuance of ordinary shares upon exercise of share options	$ 3,385			3,385						3,385
Issuance of ordinary shares upon vesting of RSUs (in shares)							1,718,202
Issuance of ordinary shares upon employee stock purchase plan (in shares)							55,876
Issuance of ordinary shares upon employee stock purchase plan	592			592						592
Share-based compensation	33,313			33,313						33,313
Return of capital to interests in consolidated VIEs	(8,420)														(8,420)
Other comprehensive income (loss)	(21,492)			(21,577)									(21,577)		85
Net income (loss)	19,055			24,548										24,548	(5,493)
Ending balance (in shares) at Jun. 30, 2025							76,161,969
Ending balance at Jun. 30, 2025	$ 467,979			366,752						1,319,312			(33,065)	(919,495)	101,227
Beginning balance (in shares) at Mar. 31, 2025	5,000,000
Beginning balance at Mar. 31, 2025	$ 74,250
Ending balance (in shares) at Jun. 30, 2025	5,000,000
Ending balance at Jun. 30, 2025	$ 74,250
Beginning balance (in shares) at Mar. 31, 2025							75,430,952
Beginning balance at Mar. 31, 2025	440,803			335,490						1,299,010			(27,370)	(936,150)	105,313
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of ordinary shares upon exercise of share options (in shares)							126,638
Issuance of ordinary shares upon exercise of share options	1,118			1,118						1,118
Issuance of ordinary shares upon vesting of RSUs (in shares)							604,379
Share-based compensation	19,184			19,184						19,184
Return of capital to interests in consolidated VIEs	(3,981)														(3,981)
Other comprehensive income (loss)	(5,708)			(5,695)									(5,695)		(13)
Net income (loss)	16,563			16,655										16,655	(92)
Ending balance (in shares) at Jun. 30, 2025							76,161,969
Ending balance at Jun. 30, 2025	$ 467,979			$ 366,752						$ 1,319,312			$ (33,065)	$ (919,495)	$ 101,227